CXCR inhibitor SB265610, Purity ≥98%

Cat. No.: X23-10-ZQ596

CXCR inhibitor SB265610, Purity ≥98%

Synonym: 211096-49-0; SB-265610; SB 265610; N-(2-BROMOPHENYL)-N'-(7-CYANO-1H-BENZOTRIAZOL-4-YL)UREA; sb265610; CHEMBL38182; 1-(2-Bromophenyl)-3-(7-cyano-2H-benzotriazol-4-yl)urea; CXCR inhibitor

  • CAS Number: 211096-49-0
  • Compound CID: 9841667
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SB265610 targets the chemokine receptors CXCR, which are part of the GPCR family. It targets CXCR2.
Molecular Weight
357.16
Molecular Formula
C14H9BrN6O
Targets
CXCR2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
SB265610 can be applied in studies focusing on its role as a selective CXCR2 antagonist in inflammatory processes.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0